For its third fiscal quarter (ending December 31), Mesa Laboratories Inc (NASDAQ: MLAB) has reported a -179% decline in E.P.S. from $0.39 a year ago to $-0.31 in the current quarter. E.P.S. were $-46.25 for the latest four quarters through December 31 versus $0.17 for the same period a year ago — a decline of -27306%.
Recent Price Action
On 2/4/25, Mesa Laboratories Inc (NASDAQ: MLAB) stock enjoyed a large increase of 2.5%, closing at $137.27. Moreover, this advance was accompanied by unusually high trading volume at 191% of normal. The stock has been exceptionally strong relative to the market over the last nine months but has declined -1.6% during the last week.
Current PriceTarget Research Rating
Mesa Laboratories has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Mesa Laboratories has a very low Appreciation Score of 14 but a very high Power Rating of 88, leading to the Neutral Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment